Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
dwarfism
Marketing
BioMarin’s commercial chief Jeffrey Ajer hits the exit
BioMarin's commercial lead Jeffrey Ajer will leave the company by July.
Ben Adams
Jan 12, 2024 10:28am
BioMarin's barnstorming Voxzogo launch creates supply bottleneck
Aug 3, 2023 7:45am
Rare disease player BridgeBio draws buyout interest: Bloomberg
Mar 28, 2023 11:10am
BioMarin on its way to turning a profit in 2022
Apr 28, 2022 9:50am
